POLYLYSINE AND CVIM SEQUENCES OF K-RASB DICTATE SPECIFICITY OF PRENYLATION AND CONFER RESISTANCE TO BENZODIAZEPINE PEPTIDOMIMETIC IN-VITRO

被引:283
作者
JAMES, GL
GOLDSTEIN, JL
BROWN, MS
机构
[1] Department of Molecular Genetics, University of Texas SW Medical Ctr., Dallas
关键词
D O I
10.1074/jbc.270.11.6221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BZA-5B, a benzodiazepine peptidomimetic, inhibits CAAX farnesyltransferase (FTase) and blocks attachment of farnesyl groups to oncogenic and wild-type H-Ras in animal cells. This compound slows the growth of cells transformed with oncogenic H-Ras at concentrations that do not affect the growth of nontransformed cells. This finding suggested that nontransformed cells may produce a form of Ras whose prenylation is resistant to BZA-5B. In the current studies, we found that FTase had a 50-fold higher affinity for K-RasB than for H-Ras in vitro. Farnesylation of K-RasB was inhibited by BZA-2B, the active form of BZA-5B, but only at concentrations that were 8-fold higher than those that inhibited farnesylation of H-Ras, K-RasB, but not H-Ras, was also a substrate for CAAX geranylgeranyltransferase-1 (GGTase-1), and its affinity for the enzyme was equal to that of Rap1B, an authentic leucine-terminated substrate for GGTase-1, Inhibition of the geranylgeranylation of K-RasB occurred only at high concentrations of BZA-2B, All of these properties of K-RasB were traced to the combined effects of its COOH-terminal CVIM sequence and the adjacent polylysine sequence, neither of which is present in H-Ras, These studies provide a potential explanation for the resistance of nontransformed cells to growth inhibition by BZA-5B, Inasmuch as the majority of Ras-related human cancers contain oncogenic versions of K-RasB rather than H-Ras, the current data suggest that in vitro studies of FTase inhibitors with potential anti-cancer activity should use authentic K-RasB as a substrate.
引用
收藏
页码:6221 / 6226
页数:6
相关论文
共 39 条
[1]  
ANDRES DA, 1993, J BIOL CHEM, V268, P1383
[2]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[3]   PROTEIN PRENYLATION - MAD BET FOR RAB [J].
BROWN, MS ;
GOLDSTEIN, JL .
NATURE, 1993, 366 (6450) :14-15
[4]   P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].
CASEY, PJ ;
SOLSKI, PA ;
DER, CJ ;
BUSS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327
[5]  
CASEY PJ, 1992, J LIPID RES, V33, P1731
[6]  
CHEN WJ, 1993, J BIOL CHEM, V268, P9675
[7]   CDNA CLONING AND EXPRESSION OF THE PEPTIDE-BINDING BETA-SUBUNIT OF RAT P21RAS FARNESYLTRANSFERASE, THE COUNTERPART OF YEAST DPR1/RAM1 [J].
CHEN, WJ ;
ANDRES, DA ;
GOLDSTEIN, JL ;
RUSSELL, DW ;
BROWN, MS .
CELL, 1991, 66 (02) :327-334
[8]   CLONING AND EXPRESSION OF A CDNA-ENCODING THE ALPHA SUBUNIT OF RAT P21RAS PROTEIN FARNESYLTRANSFERASE [J].
CHEN, WJ ;
ANDRES, DA ;
GOLDSTEIN, JL ;
BROWN, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11368-11372
[9]   SPECIFIC ISOPRENOID MODIFICATION IS REQUIRED FOR FUNCTION OF NORMAL, BUT NOT ONCOGENIC, RAS PROTEIN [J].
COX, AD ;
HISAKA, MM ;
BUSS, JE ;
DER, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2606-2615
[10]  
CREMERS FPM, 1994, J BIOL CHEM, V269, P2111